EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrative Analysis of Cellular Senescence-Related Genes Identifies FOLR1 as a Novel Tumor Suppressor and a Potential Therapeutic Target in Lung Adenocarcinoma

Fei Wang, Chang Xie iD, Min Zhang, Xiangyang Wu, Xinqi Sun, Yan Li iD, Zhibing Ming

Cancers · 22.04.2026 · 18 (9) · 1330

DOI: 10.3390/cancers18091330 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 22.04.2026. Verfasst von Fei Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, Southeast University Affiliated Nantong First People's Hospital, Nantong 226001, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Nantong First People's Hospital Provincial and Ministerial Level High-level Science and Technology Project Cultivation Fund, the Nantong Municipal Health Commission Scientific Research Project (Directive), the Nantong First People’s Hospital Provincial and Ministerial Level High-level Science and Technology Project Cultivation Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cellular senescence is a key regulatory mechanism in tumor initiation and progression, influencing cancer development through modulation of the cell cycle, the immune microenvironment, and inflammatory responses. However, the molecular characteristics and potential clinical value of senescence-related genes in lung adenocarcinoma (LUAD) have not been systematically elucidated. This study aimed to comprehensively characterize the expression patterns, molecular subtypes, and prognostic significance of cellular senescence-related genes in LUAD, and to identify key regulatory determinants.

Methods

Transcriptomic data of cellular senescence-related genes were obtained from The Cancer Genome Atlas (TCGA) cohort, and integrated analyses were performed to characterize their mutational landscape, copy number variations, and differential expression profiles. Senescence-related molecular subtypes were established using consensus clustering, followed by gene set variation analysis (GSVA) for pathway enrichment and immune infiltration analyses. A prognostic risk model was subsequently constructed using LASSO-penalized Cox regression, and its predictive performance was systematically evaluated. Candidate key regulators were further prioritized through bioinformatic screening, identifying FOLR1 as a hub gene. The biological function of FOLR1 was validated by qRT–PCR, Western blotting, assessment in clinical specimens, and a subcutaneous xenograft tumor model in mice.

Results

Cellular senescence-related genes in LUAD exhibited a high frequency of somatic mutations and copy number alterations, accompanied by marked transcriptional dysregulation. Based on the expression profiles of these genes, LUAD patients could be stratified into three distinct molecular subtypes with significantly different clinical outcomes. These subtypes displayed pronounced heterogeneity in pathway enrichment patterns and immune cell infiltration. The subsequently developed prognostic signature demonstrated robust predictive performance in both the training and validation cohorts. Functional assays showed that FOLR1 was significantly downregulated in LUAD tissues and cell lines; FOLR1 knockdown promoted tumor cell proliferation, whereas restoration of its expression or pharmacological intervention markedly suppressed tumor progression. Consistently, in vivo xenograft experiments further corroborated the tumor-suppressive role of FOLR1 in lung adenocarcinoma.

Conclusions

This study systematically delineated the molecular landscape of cellular senescence-related genes in LUAD and elucidated their associations with the tumor immune microenvironment and patient prognosis. Moreover, FOLR1 was identified as a potential tumor suppressor and therapeutic target. These findings provide a theoretical basis for senescence-informed molecular stratification and the development of precision treatment strategies in lung adenocarcinoma.

Schlagwörter

Stichwörter der Autor:innen

FOLR1cellular senescencelung adenocarcinomaprognostic modeltumor immune microenvironment

Autor:innen und Institutionen

  • Department of Cardiovascular Surgery, Southeast University Affiliated Nantong First People's Hospital, Nantong 226001, China.
  • Department of Vascular Surgery, Affiliated Nantong Clinical College of Nantong University, Nantong First People's Hospital, Nantong 226001, China.
  • Department of Vascular Surgery, Southeast University Affiliated Nantong First People's Hospital, Nantong 226001, China.

ORCID-Profile: Chang Xie, Yan Li

Förderung

  • the Nantong First People's Hospital Provincial and Ministerial Level High-level Science and Technology Project Cultivation Fund
  • the Nantong Municipal Health Commission Scientific Research Project (Directive)
  • the Nantong First People’s Hospital Provincial and Ministerial Level High-level Science and Technology Project Cultivation Fund

Zitieren

APA

Wang, F., Xie, C., Zhang, M., Wu, X., Sun, X., Li, Y., & Ming, Z. (2026). Integrative Analysis of Cellular Senescence-Related Genes Identifies FOLR1 as a Novel Tumor Suppressor and a Potential Therapeutic Target in Lung Adenocarcinoma. Cancers, 18(9), 1330. https://doi.org/10.3390/cancers18091330

Vancouver

Wang F, Xie C, Zhang M, Wu X, Sun X, Li Y, et al. Integrative Analysis of Cellular Senescence-Related Genes Identifies FOLR1 as a Novel Tumor Suppressor and a Potential Therapeutic Target in Lung Adenocarcinoma. Cancers. 2026;18(9):1330. doi:10.3390/cancers18091330

BibTeX
@article{Wang2026,
  author = {Wang, Fei and Xie, Chang and Zhang, Min and Wu, Xiangyang and Sun, Xinqi and Li, Yan and Ming, Zhibing},
  title = {Integrative Analysis of Cellular Senescence-Related Genes Identifies FOLR1 as a Novel Tumor Suppressor and a Potential Therapeutic Target in Lung Adenocarcinoma},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {9},
  pages = {1330},
  doi = {10.3390/cancers18091330}
}
Kostenlos starten →